Antiplatelet Medication in Patients with Vascular Disease and Following Interventions
| dc.contributor.author | Schanzer, Andres | |
| dc.contributor.author | Ho, Karen J. | |
| dc.contributor.author | Belkin, Michael | |
| dc.date | 2022-08-11T08:10:58.000 | |
| dc.date.accessioned | 2022-08-23T17:27:03Z | |
| dc.date.available | 2022-08-23T17:27:03Z | |
| dc.date.issued | 2010-01-01 | |
| dc.date.submitted | 2011-06-20 | |
| dc.identifier.citation | Schanzer A, Ho K, Belkin, M. Antiplatelet Medication in Patients with Vascular Disease and Following Interventions. In <em>The Ischemic Extremity: New Findings and Treatment</em> (Modern Trends in Vascular Surgery series). Edited by Pearce W, Rodriguez H, Yao J. PMPH-USA, 2010, p. 69-78. ISBN 1607950502, 9781607950509.<strong></strong> Full preview of chapter available via Google Books. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/49773 | |
| dc.description.abstract | Summary: This chapter will concentrate on the patient with peripheral vascular disease, and will review the role of antiplatelet therapy in providing protection from major cardiovascular morbidity (myocardial infarction, stroke, or death), improved bypass graft patency, and decreased rates of restinosis and occlusion following peripheral percutaneous intervention. | |
| dc.language.iso | en_US | |
| dc.relation.url | http://books.google.com/books?id=8jCRCRGagy4C | |
| dc.subject | Vascular Diseases | |
| dc.subject | Peripheral Arterial Disease | |
| dc.subject | Platelet Aggregation Inhibitors | |
| dc.subject | Surgery | |
| dc.title | Antiplatelet Medication in Patients with Vascular Disease and Following Interventions | |
| dc.type | Book Chapter | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/surgery_pp/43 | |
| dc.identifier.contextkey | 2067845 | |
| html.description.abstract | <p>Summary: This chapter will concentrate on the patient with peripheral vascular disease, and will review the role of antiplatelet therapy in providing protection from major cardiovascular morbidity (myocardial infarction, stroke, or death), improved bypass graft patency, and decreased rates of restinosis and occlusion following peripheral percutaneous intervention.</p> | |
| dc.identifier.submissionpath | surgery_pp/43 | |
| dc.contributor.department | Department of Surgery |